HTG Molecular Diagnostics, Inc. (Formerly Known as High Throughput Genomics, Inc.) Appoints John Lubniewski to Chief Business Officer

TUCSON, Ariz.--(BUSINESS WIRE)--HTG Molecular Diagnostics, provider of molecular technology solutions, today announced the appointment of John Lubniewski to Chief Business Officer.

“John has extensive experience in strategic marketing, product development and business unit management and he is adeptly suited to both strengthen our existing sales and marketing efforts for existing products as well as help to drive development of new technologies and offerings for HTG Molecular Diagnostics”

Mr. Lubniewski brings more than 20 years of management experience in the life science sector to this newly created position at HTG. He will be responsible for leading the sales, marketing and product development teams for HTG’s three strategic business areas: molecular testing capabilities for translational medicine, pharmaceutical clinical development and pathology laboratory diagnostics.